NYSEARCA:XBISPDR S&P Biotech ETF Stock Price, Forecast & News

$80.40

+5.54 (+7.40 %)

(As of 04/7/2020 03:48 AM ET)

Add

Today's Range

$77.79

Now: $80.40▼

$80.50

50-Day Range

$65.95

MA: $82.61▼

$98.35

52-Week Range

$62.94

Now: $80.40▼

$98.79

Volume7.36 million shs

Average Volume7.28 million shs

Market Capitalization$3.43 billion

P/E RatioN/A

Dividend Yield0.01%

BetaN/A

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for SPDR S&P Biotech ETF.

2.3 Community Rank

Outperform Votes
SPDR S&P Biotech ETF has received 113 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
SPDR S&P Biotech ETF has received 133 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
SPDR S&P Biotech ETF has received 54.07% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about SPDR S&P Biotech ETF and other stocks. Vote “Outperform” if you believe XBI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XBI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
SPDR S&P Biotech ETF has a dividend yield of 0.01%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
SPDR S&P Biotech ETF does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SPDR S&P Biotech ETF insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

0.46 out of 5 stars

Basic Details

Issuer SSgA

Fund NameSPDR S&P Biotech ETF

Tax ClassificationRegulated Investment Company

SymbolNYSEARCA:XBI

Inception Date1/31/2006

Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio

Webhttp://www.spdrs.com/

Phone+1-866-7872257

Fund Focus

Asset ClassEquity

BenchmarkS&P Biotech Index

CategorySector

FocusHealth Care

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$3.10 billion

Average Daily Volume$10.65 million

Discount/Premium-0.12%

ETF Expenses

Management Fee0.35%

Other Expenses0.00%

Total Expenses0.35%

Fee Waiver0.00%

Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSGA Funds Management, Inc.

AdvisorSSgA Funds Management, Inc.

CustodianState Street Bank and Trust Company

DistributorState Street Global Advisors Funds Distributors, LLC

Transfer AgentState Street Bank and Trust Company

Trustee

Lead Market MakerVirtu Financial

Receive XBI News and Ratings via Email

Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Currency Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sector Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Industry Exposure of SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions

How has SPDR S&P Biotech ETF's stock been impacted by COVID-19 (Coronavirus)?

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, XBI shares have increased by 1.8% and is now trading at $80.40. View which stocks have been mosted impacted by Coronavirus.

How often does SPDR S&P Biotech ETF pay dividends? What is the dividend yield for SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF declared a quarterly dividend on Friday, December 20th. Stockholders of record on Monday, December 23rd will be paid a dividend of $0.0009 per share on Thursday, December 26th. This represents a $0.00 annualized dividend and a dividend yield of 0.00%. The ex-dividend date of this dividend is Friday, December 20th. View SPDR S&P Biotech ETF's dividend history.

Has SPDR S&P Biotech ETF been receiving favorable news coverage?

Media coverage about XBI stock has trended very negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. SPDR S&P Biotech ETF earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave media headlines about the exchange traded fund a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutSPDR S&P Biotech ETF.

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include iShares Nasdaq Biotechnology ETF (IBB), NVIDIA (NVDA), Netflix (NFLX), Intel (INTC), Alibaba Group (BABA), Advanced Micro Devices (AMD), Micron Technology (MU), AT&T (T), Cisco Systems (CSCO) and Walt Disney (DIS).

Who are SPDR S&P Biotech ETF's key executives?

SPDR S&P Biotech ETF's management team includes the following people:

James E. Ross, President, Trustee (Age 52)
Peter A. Ambrosini, Chief Compliance Officer (Age 69)
Michael P. Riley, Vice President (Age 44)
Gary L. French, Treasurer (Age 64)
John W. Clark, Assistant Treasurer (Age 46)
Matthew W. Flaherty, Assistant Treasurer (Age 42)
Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
Mary Moran Zeven, Secretary (Age 52)
Scott M. Zoltowski, Assistant Secretary (Age 44)
Dave Kelly, Independent Trustee

What is SPDR S&P Biotech ETF's stock symbol?

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's stock is owned by many different institutional and retail investors. Top institutional investors include McGuire Investment Group LLC (0.25%) and Corrado Advisors LLC (0.02%).

Which major investors are buying SPDR S&P Biotech ETF stock?

XBI stock was bought by a variety of institutional investors in the last quarter, including McGuire Investment Group LLC, and Corrado Advisors LLC.

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SPDR S&P Biotech ETF's stock price today?

One share of XBI stock can currently be purchased for approximately $80.40.

How big of a company is SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF has a market capitalization of $3.43 billion. View additional information about SPDR S&P Biotech ETF.

What is SPDR S&P Biotech ETF's official website?

The official website for SPDR S&P Biotech ETF is http://www.spdrs.com/.

How can I contact SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Featured Article: Average Daily Trade Volume Explained